Insider transactions Telix Pharmaceuticals Limited
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.78 AUD | -1.31% |
|
-6.57% | +40.89% |
| 07-10 | ASX Biggest Losers | MT |
| 07-03 | Telix Pharmaceuticals Securing FDA Nod in Line With Expectations, Says Jefferies, Shares Down 3% | MT |
Insider Transaction History
Latest insider transactions for Telix Pharmaceuticals Limited
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 06-10 | Buy | Director | 10,200 | 9.43 | 96.22K | 0.0030% | ||
| 05-25 | Free | Director | 30,048 | - | - | 0.0089% | ||
| 05-25 | Free | Director | 23,139 | - | - | 0.0068% | ||
| 05-25 | Free | Founder | 339,845 | - | - | 0.1001% | ||
| 05-25 | Free | Director | 21,597 | - | - | 0.0064% | ||
| 05-25 | Free | Director | 21,597 | - | - | 0.0064% | ||
| 05-25 | Free | Founder | 27,121 | - | - | 0.0080% | ||
| 04-28 | Buy | Founder | 67,935 | 14.67 | 997K | 0.0200% | ||
| 04-27 | Buy | Founder | 67,935 | 14.67 | 997K | 0.0200% | ||
| 03-28 | Fiscal year | Chief Financial Officer | 2,222 | - | - | 0.0007% | ||
| 03-17 | Other | Director | 3,719 | - | - | 0.0011% | ||
| 03-17 | Other | Chairman | 3,628,750 | - | - | 1.0711% | ||
| 03-17 | Other | Founder | 21,524,938 | - | - | 6.3537% | ||
| 03-17 | Other | Director | 595,000 | - | - | 0.1756% | ||
| 03-17 | Other | Chief Operating Officer | 112,177 | - | - | 0.0331% | ||
| 03-17 | Other | Chief Financial Officer | 193,071 | - | - | 0.0570% | ||
| 03-17 | Other | Chief Technology Officer | 548,181 | - | - | 0.1618% | ||
| 03-16 | Expiration | Founder | 20,045 | - | - | 0.0059% | ||
| 11-05 | Fiscal year | Founder | 100,708 | 15.56 | 1.57M | 0.0298% | ||
| 16/06/25 | Free | Founder | 2,595 | - | - | 0.0008% | ||
| 16/06/25 | Free | Founder | 166,483 | - | - | 0.0494% | ||
| 10/03/25 | Expiration | Founder | 46,558 | - | - | 0.0138% | ||
| 05/03/25 | Buy | Director | 3,719 | 26.91 | 100K | 0.0011% | ||
| 04/03/25 | Buy | Chairman | 11,315 | 28.23 | 319K | 0.0034% | ||
| 03/03/25 | Sell | Chairman | 30,000 | 30.43 | 913K | 0.0089% | ||
| 25/02/25 | Sell | Founder | 2,000,000 | 29.50 | 59M | 0.5975% | ||
| 25/06/24 | Free | Founder | 144,037 | - | - | 0.0431% | ||
| 20/01/24 | Fiscal year | Founder | 153,298 | 11.00 | 1.69M | 0.0474% | ||
| 31/05/23 | Free | Founder | 120,268 | - | - | 0.0378% | ||
| 15/03/23 | Buy | Chairman | 51,305 | 6.69 | 343K | 0.0162% | ||
| 13/12/22 | Buy | Chairman | 10,930 | 6.70 | 73.23K | 0.0035% | ||
| 08/11/22 | Fiscal year | Director | 495,000 | - | - | 0.1581% | ||
| 08/11/22 | Expiration | Director | 495,000 | - | - | 0.1581% | ||
| 04/06/22 | Buy | Chairman | 33,000 | 4.09 | 135K | 0.0106% | ||
| 22/05/22 | Free | Chairman | 52,070 | 2.18 | 114K | 0.0167% | ||
| 22/05/22 | Free | Founder | 139,672 | - | - | 0.0447% | ||
| 26/04/22 | Buy | Director | 250,000 | 4.37 | 1.09M | 0.0804% | ||
| 02/02/22 | Fiscal year | Founder | 400,000 | 1.09 | 436K | 0.1302% | ||
| 29/01/22 | Sell | Founder | 2,000,000 | 7.70 | 15.4M | 0.7016% | ||
| 29/01/22 | Sell | Founder | 2,000,000 | 7.70 | 15.4M | 0.7016% | ||
| 27/09/21 | Fiscal year | Chairman | 990,000 | 0.85 | 842K | 0.3515% | ||
| 27/09/21 | Fiscal year | Chairman | 990,000 | 0.85 | 842K | 0.3515% | ||
| 27/09/21 | Fiscal year | Chairman | 990,000 | 0.85 | 842K | 0.3515% | ||
| 27/09/21 | Fiscal year | Chairman | 990,000 | 0.85 | 842K | 0.3515% | ||
- Stock Market
- Stocks
- TLX Stock
- Company Telix Pharmaceuticals Limited
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















